Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow HSIC
Henry Schein, Inc. (HSIC) Return on assets
Henry Schein, Inc.'s return on assets over the twelve months to 30 June 2026 was 3.62%, down 0.1 percentage points from fiscal 2025 (3.71%). Over the past ten years it has ranged from 3.71% (fiscal 2025) to 8.88% (fiscal 2019) — the current reading is the lowest in ten years. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 3.71% | (0.04) |
| FY2024 | 3.75% | (0.59) |
| FY2023 | 4.34% | (1.96) |
| FY2022 | 6.30% | (1.46) |
| FY2021 | 7.76% | 2.35 |
| FY2020 | 5.41% | (3.47) |
| FY2019 | 8.88% | 2.33 |
| FY2018 | 6.55% | 0.99 |
| FY2017 | 5.56% | (2.08) |
| FY2016 | 7.64% | 0.06 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| MCK McKesson Corporation compare | 5.41% |
| HSIC Henry Schein, Inc. | 3.62% |
| COR Cencora, Inc. compare | 3.33% |
| CAH Cardinal Health, Inc. compare | 3.10% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.00% |
| ACH Accendra Health, Inc. compare | −9.65% |
| COSM Cosmos Health Inc. compare | −39.6% |
| FOCL FocalTherics compare | −50.3% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement